Inside Mount Sinai

In this issue:

  • James Ferrara, MD, is leading a world-class research program at Mount Sinai to treat graft-versus-host disease, a serious complication of bone marrow transplantation.

  • Ron Shapiro, MD, joins Mount Sinai’s Recanati Miller Transplantation Institute as the new Surgical Director of the Kidney and Pancreas Transplant Program.

  • Mount Sinai researchers, under Adolfo Garcia-Sastre, PhD, have identified 53 FDA-approved drugs that may help fight the Ebola virus.

  • The Mount Sinai Health System has partnered with Empire BlueCross BlueShield to manage all aspects of care for Empire’s 48,000 commercial and Medicare members.

  • Kristjan Ragnarsson, MD, has received a lifetime achievement award from the American Academy of Physical Medicine and Rehabilitation.

  • Mount Sinai Health System nurses were recognized for extraordinary achievements in a Tribute to Nurses, the special New York Times Magazine advertising section; STRIVE has named Mount Sinai an Outstanding Partner of the Year for its efforts in hiring East Harlem residents; and Will Parker, a security worker at Mount Sinai Beth Israel, is also a singer and composer who performs at fine hotels in New York City. On February 2, he will perform on the Mount Sinai Beth Israel campus.

View the PDF


This Content Component encountered an error